Search for: "Li v. Johnson et al" Results 21 - 40 of 47
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Oct 2022, 5:14 am by INFORRM
Canada The Superior Court of Justice, Ontario handed down judgement in Marcellin v LPS et all 2022 ONSC 5886. [read post]
28 Dec 2022, 6:20 am by Richard Hunt
Sanchez et al, 2022 WL 1749131 (Dec. 6, 2022) Magistrate Judge Chestney found these allegations were sufficient, and in particular that they met the plausibility standard required by Iqbal and Twombly. [read post]
13 Jul 2009, 6:45 am
(IP finance) Patent perishables – The effects on a company’s patent portfolio when it goes bust (IPEG)   Canada Supreme Court rejects application to appeal procedural ruling in copyright case over photos showing marijuana plants growing in the plaintiff’s residence: Agnieska Wojtanowska, et al v Daniel Mustard, et al (Excess Copyright) Federal Court sets high standard of evidentiary detail, reaffirms local… [read post]
17 Jun 2022, 12:05 pm by Richard Hunt
Mgmt Properties IV, LLC et al, 2022 WL 2079716, at *5 (S.D. [read post]
7 Nov 2022, 2:57 am by INFORRM
Croxall was taken off the air on 24 October 2022, after she was alleged to have shown bias when Boris Johnson pulled out of the Tory leadership contest. [read post]
20 Jun 2018, 11:53 am by Philip Bobbitt
It is, as Chief Justice John Marshall observed of the commerce power in McCulloch v. [read post]
15 Dec 2019, 4:05 pm by INFORRM
  He took part in the BBC’s live televised Tory leadership debate questioning the candidate on issues of islamophobia, which led to Boris Johnson agreeing to conduct a formal investigation into Islamophobia in the Conservative Party if he became its leader. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]